ARCHIMEDlife News
-
WORLDSymposium 2025 Poster Presentations – Updates on important diagnostic services
The WORLDSymposium for Lysosomal Storage Disorders convened in San Diego, CA, USA earlier this month. This important meeting brings together industry, physicians, advocate groups, and… Read more -
Newborn Screening and Presymptomatic Treatment of Metachromatic Leukodystrophy
Metachromatic leukodystrophy (MLD) is a lysosomal storage disorder characterized by progressive neurodegeneration due to a deficiency in the enzyme arylsulfatase-A (ARSA). This deficiency leads to… Read more
-
MedLab Dubai. New directors appointed.
ARCHIMEDlife News October 23, 2023New directors appointed: @Gröning, MD, as Medical Director, Dr. med. Thomas Winkler , MD and David C. Kasper (also as Manager). Our mission together with our highly experienced local… Read more -
In-person Conferences once again!
With the start of 2022, ARCHIMEDlife is pleased to announce that we will be once again attending in-person conferences! The WORLDSymposium for lysosomal disease research… Read more
-
The amedes group supports the NCL Foundation in Germany
ARCHIMEDlife News May 7, 2021In January, the amedes group called on their employees to nominate charitable organizations to be supported by the amedes group in the future. The overwhelming… Read more
-
New testing options for Cerebrotendinous Xanthomatosis (CTX)
About CTX: CTX (cerebrotendinous xanthomatosis) is a rare and serious disease of bile acid metabolism with an estimated incidence of about 1:50,000. The disease is… Read more